Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548716 · ClinicalTrials.gov registry record
A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients
A clinical trial, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- 50
- Enrollment target
NCT01548716: Completed study, sponsored by Winthrop University Hospital.
NCT01548716 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01548716 has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Hypothesis: 25-hydroxy vitamin D levels in non-itching hemodialysis (HD) patients will be higher than those in HD patients with itching 25-hydroxy vitamin D levels will be measured in non-itching hemodialysis patients and compared to levels previously measured in a previous study of 25-hydroxy vitamin D levels of patients complaining of itching.
Primary Outcome
Pt will have blood sample taken and fill out 1) Pruritis Survey 2) Phosphorus Restriction Compliance Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-02 |
What the finished NCT01548716 record still lists
NCT01548716 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01548716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01548716 about?
NCT01548716 is a clinical study titled "A Study of 25-hydroxy Vitamin d Levels in Non-itching Hemodialysis Patients". Hypothesis: 25-hydroxy vitamin D levels in non-itching hemodialysis (HD) patients will be higher than those in HD patients with itching 25-hydroxy vitamin D levels will be measured in non-itching hemodialysis patients and compared to levels previously measured in a previous study of 25-hydroxy vit...
What is the current status of trial NCT01548716?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2011-09. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01548716?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia